TearScience Raises $44.5 Million
TearScience, a Morrisville, N.C.-based developer of a device to diagnose and treat chronic dry eye disease, has raised $44.5 million in Series C funding. New backers include Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. Returning shareholders include De Novo Ventures, Spray Ventures and Quaker Bio Ventures.
5 May 2010•3 mins read
